I thought I share the following video link and I apologise if it has been posted here before. For me, the video speaks a thousand words and reaffirms my belief as to why I am invested in MSB from a future medicinal breakthrough standpoint and equally as important from a shareholder’s perspective.
The video shows one of the patients in the NIH-sponsored LVAD trial. It’s worth reading his story and watching him run.
And before we get the usual attack from the same posters, yes! it’s randomised, and that’s why this patient says he doesn’t know whether or not he’s received the cells. However, even blind Freddy can observe that this patient is experiencing what is like to feel when you are healthy. I believe that our bodies produce this wonderful stem cells and through medical breakthroughs, they may provide the answer to many unmet medical needs.
MSB has told us that this 159-patient NIH-sponsored trial in end-stage heart failure patients receiving an implantable left ventricular assist device (LVAD) is due to complete enrolment soon with an interim read-out expected later this year.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)